Iontophoresis-Based Topical Drug Delivery for Dermatologic Conditions: A Systematic Review. [PDF]
Piscazzi F +3 more
europepmc +1 more source
ABSTRACT Background Cutaneous T‐cell lymphoma (CTCL) is a rare and heterogeneous group of skin‐homing lymphomas with a largely unknown pathogenesis. Staphylococcus aureus (S. aureus) colonization has been implicated in exacerbating CTCL, particularly in advanced stages. Objectives This study assessed the prevalence of S.
Ida Lind Holm +9 more
wiley +1 more source
Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy. [PDF]
Davis M +5 more
europepmc +1 more source
Prevention and Management of Dermatologic Adverse Events in Patients Treated with Amivantamab Plus Lazertinib. [PDF]
Szwed C +4 more
europepmc +1 more source
A Case of Cutaneous B Lymphoblastic Lymphoma With Multiple Cutaneous Tumors
ABSTRACT A 17‐year‐old Japanese male patient was referred to our hospital due to an erythematous tumor on part of the right mandible that had developed 3 months earlier, and similar tumors had appeared on the trunk and lower extremities. A complete blood count showed no specific abnormalities.
Tomomichi Shimizu +4 more
wiley +1 more source
Pityriasis Lichenoides et Varioliformis Acuta Associated With Tirzepatide: A First Report. [PDF]
Deniz MS +8 more
europepmc +1 more source
ABSTRACT Differentiation syndrome (DS) and Sweet syndrome (SS) are inflammatory complications mediated by cytokine dysregulation, classically associated with therapies that promote myeloid differentiation or cytokine release. While DS has been primarily linked to all‐trans retinoic acid (ATRA) and IDH inhibitors, recent evidence suggests that ...
Katerina Grafanaki +6 more
wiley +1 more source
A comprehensive analysis of the adverse drug events of metastatic and unresectable gastrointestinal stromal tumor treatment options: avapritinib, imatinib, regorafenib, ripretinib, and sunitinib safety insights and implications. [PDF]
Thompson CM, Andrews MB, Adler DG.
europepmc +1 more source
ABSTRACT Paradoxical atopic dermatitis (AD) can arise during biologic therapy for psoriasis due to an immune‐axis imbalance. We describe a 47‐year‐old man who developed severe AD while receiving secukinumab, which was successfully managed with the addition of dupilumab, allowing long‐term control of both diseases.
So Yun Park +6 more
wiley +1 more source
Bloodstream Infection in an Immunocompromised Host After Unusual Presentation of Photo Recall Dermatitis. [PDF]
Immel S +3 more
europepmc +1 more source

